|
|||||||||||||||||||||||||||
| Tools -> Policy makers ->Structured Summaries -> Glossary |
| A | B | C | D | E | F | G | H | I | J | K | L | M |
| N | O | P | Q | R | S | T | U | V | W | X | Y | Z |
Test of association
A statistical test to assess whether the value of one variable is associated (i.e. varies with) the value of another variable, or
whether the presence or absence of a factor is more likely when a
particular outcome is present. See also correlation.
Time to event
A description of the data in studies where the analysis relates not
just to whether an event occurs but also when. Such data are analysed
using survival
analysis. (Also called survival data.)
Tolerability
[of an intervention:] usually refers to medically less important (that
is, without serious or permanent sequelae), but unpleasant adverse effects of drugs. These include symptoms such as dry mouth, tiredness, etc,
that can affect a person’s quality of life and willingness to
continue the treatment. As these adverse effects usually develop early
on and are relatively frequent, randomised controlled trials may yield
reliable data on their incidence.
Toxicity
The degree to which a medicine is poisonous. How much of a
medicine can be taken before it has a toxic effect.
Treatment
The process of intervening on people
with the aim
of enhancing health or life expectancy. Sometimes, and particularly in
statistical texts, the word is used to cover all comparison groups,
including placebo and no
treatment arms of a controlled
trial and even interventions designed
to prevent bad outcomes in
healthy people,
rather than cure ill people. See also intervention, experimental
intervention and control.
Treatment effect
See estimate
of effect
Trialist
Used to refer to a person conducting or publishing a controlled trial.
Type I error
A conclusion that a treatment works,
when it actually does not work. The risk of a Type I error is often
called alpha. In a statistical test, it describes the chance of
rejecting the null hypothesis when it is in fact true. (Also called false positive.)
Type II error
A conclusion that there is no
evidence that a treatment works, when it actually does work. The risk of a Type II error is often
called beta. In a statistical test, it describes the chance of not
rejecting the null hypothesis when it is in fact false. The risk of a Type II error
decreases as the number of participants in a study increases. (Also called false negative.)